World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
25421
World Ranking
16086
National Ranking
183

Overview

Chak Sing Lau is affiliated with the University of Hong Kong in China and has an extensive research portfolio primarily in the field of medicine. Their work covers multiple subfields including rheumatology, infectious diseases, immunology, epidemiology, and genetics.

The researcher has contributed significantly to topics such as systemic lupus erythematosus research, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, rheumatoid arthritis research and therapies, atherosclerosis and cardiovascular diseases, spondyloarthritis studies and treatments, and drug-induced adverse reactions.

Recent notable papers include:

  • Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial (2020, The Lancet)
  • Evaluation of rapid antigen test for detection of SARS-CoV-2 virus (2020, Journal of Clinical Virology)
  • Short- and potential long-term adverse health outcomes of COVID-19: a rapid review (2020, Emerging Microbes & Infections)
  • Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups (2021, Nature Communications)
  • Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study (2023, EClinicalMedicine)

The scientist frequently collaborates with several co-authors, including Philip H. Li, Ian Chi Kei Wong, Eric Yuk Fai Wan, Xue Li, and Vera Golder.

Their work is regularly published in venues such as Annals of the Rheumatic Diseases, Hong Kong Medical Journal, Lara D. Veeken, The Lancet Rheumatology, and The Journal of Rheumatology.

Best Publications

  • Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

    Ivan Fan Ngai Hung;Kwok Cheung Lung;Eugene Yuk Keung Tso;Raymond Liu

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

    T M Chan;F K Li;C S Tang;R W Wong

  • Pathogenesis of systemic lupus erythematosus

    C C Mok;C S Lau

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

    Tak Mao Chan;Fu Keung Li;Colin S.O. Tang;Raymond W.S. Wong

  • Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

    Kate Franklyn;Chak Sing Lau;Sandra V Navarra;Worawit Louthrenoo

  • Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.

    Wanling Yang;Nan Shen;Dong-Qing Ye;Qiji Liu;Qiji Liu

  • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

    David M Reid;Jean-Pierre Devogelaer;Kenneth Saag;Christian Roux

  • Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.

    Yi Ren;Jinling Tang;M. Y. Mok;Albert W. K. Chan

  • Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus

    Chi Chiu Mok;Jerry S. Lanchbury;David Wai Chan;Chak Sing Lau

  • Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

    Chi Chiu Mok;Chak Sing Lau;Raymond Woon Sing Wong

  • Ethnic and geographical differences in systemic lupus erythematosus : an overview

    C S Lau;G Yin;M Y Mok

  • How we flipped the medical classroom

    Neel Sharma;C. S. Lau;Iain Doherty;Darren Harbutt

  • A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population

    C. C. Mok;K. W. Lee;C. T. K. Ho;C. S. Lau

  • EFFECTS OF FISH OIL SUPPLEMENTATION ON NON-STEROIDAL ANTI—INFLAMMATORY DRUG REQUIREMENT IN PATIENTS WITH MILD RHEUMATOID ARTHRITIS—A DOUBLE-BLIND PLACEBO CONTROLLED STUDY

    C. S. Lau;K. D. Morley;J. J. F. Belch

  • Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.

    Chi Chiu Mok;King Yee Ying;Sydney Tang;Chung Ying Leung

  • Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians

    Wanling Yang;Huayang Tang;Yan Zhang;Xianfa Tang

  • Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.

    Chi Chiu Mok;King Yee Ying;Woon Leung Ng;Ka Wing Lee

  • IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation

    Min Yang;Min Yang;Jun Deng;Yang Liu;King-Hung Ko

  • Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.

    C C Mok;C S Lau;E Y Chan;R W Wong

  • Short- and potential long-term adverse health outcomes of COVID-19: a rapid review.

    T. Y. M. Leung;A. Y. L. Chan;E. W. Chan;V. K. Y. Chan

Frequent Co-Authors

Yu-Lung Lau
Yu-Lung Lau University of Hong Kong
Tak Mao Chan
Tak Mao Chan University of Hong Kong
Jill J. F. Belch
Jill J. F. Belch University of Dundee
Eric F. Morand
Eric F. Morand Monash University
Hung-Fat Tse
Hung-Fat Tse University of Hong Kong
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Jean-Pierre Devogelaer
Jean-Pierre Devogelaer Université Catholique de Louvain
Pak C. Sham
Pak C. Sham University of Hong Kong
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Stacey S. Cherny
Stacey S. Cherny Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative degree options can open up new opportunities within healthcare. If you’re seeking advanced roles, dnp programs online offer a convenient way for nurses to achieve the highest clinical qualifications while balancing work and study.

For those looking to enter the nursing field quickly, a fast lpn program can provide a fast-tracked path to licensure, ideal for career changers or recent graduates eager to begin work.

Specializing in mental health is increasingly in demand. Completing one of the psychiatric np programs online enables registered nurses to move into advanced mental health practice with flexibility and speed.

If your interest lies in healthcare management rather than direct patient care, pursuing an affordable healthcare administration degree online can prepare you for leadership roles without a significant financial burden.

Each of these online pathways gives students the flexibility to build a rewarding healthcare career tailored to their interests and schedule.

Best Scientists Citing Chak Sing Lau

Trending Scientists

Recently Published Articles